Analgesia, Sedation, Paralytics, Delirium, and Iatrogenic Withdrawal

Kevin Valentine1, Janelle Kummick2

  • 1Indiana University School of Medicine, Riley Hospital for Children, 705 Riley Hospital Drive, Suite 4900, Indianapolis, IN 46202, USA.

Insights

Managing pain and anxiety in critically ill children requires careful medication use. Minimizing sedatives and polypharmacy can reduce risks like delirium and withdrawal in pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric pharmacology

Background:

  • Critically ill children often require medications for pain and anxiety management.
  • Pediatric patients exhibit unique pharmacokinetic and pharmacodynamic profiles distinct from adults.

Purpose of the Study:

  • To emphasize the importance of considering pediatric-specific differences in medication use.
  • To highlight strategies for safe and effective pain and anxiety management in children.
  • To underscore the evolving understanding of sedation safety in pediatric intensive care.

Main Methods:

  • Review of current literature on pediatric pain and anxiety management.
  • Analysis of pharmacokinetic and pharmacodynamic differences between children and adults.
  • Examination of studies on sedation safety and its impact on patient outcomes.

Main Results:

  • Pediatric-specific pharmacokinetic and pharmacodynamic considerations are crucial for safe medication administration.
  • Addressing pain is essential, while judicious use of sedatives is recommended.
  • Minimizing exposure to multiple medications is associated with reduced incidence of delirium and iatrogenic withdrawal.

Conclusions:

  • Safe medication practices in critically ill children necessitate attention to age-related physiological differences.
  • Optimizing pain relief and minimizing sedative exposure are key components of modern pediatric intensive care.
  • Reducing polypharmacy is a vital strategy for improving outcomes and mitigating adverse events such as delirium and withdrawal.

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
747
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
212
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
249
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
827
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
486
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
513